Horizon Therapeutics Public Ltd Co

RHUMBLINE ADVISERS

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/9/2023

Shares

306,817

Value ($000)

35,496

Weight

0.0%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/9/2023	35,496	0.0%	306,817	9/30/2023
2023 Q2	8/8/2023	32,000	0.0%	311,132	6/30/2023
2023 Q1	5/11/2023	29,847	0.0%	273,475	3/31/2023
2022 Q4	2/14/2023	29,179	0.0%	256,402	12/31/2022
2022 Q3	11/10/2022	15,445	0.0%	249,560	9/30/2022
2022 Q2	8/11/2022	18,709	0.0%	234,560	6/30/2022
2022 Q1	5/12/2022	20,609	0.0%	195,888	3/31/2022
2021 Q4	2/10/2022	21,388	0.0%	198,474	12/31/2021
2021 Q3	11/12/2021	21,303	0.0%	194,480	9/30/2021
2021 Q2	8/5/2021	19,563	0.0%	208,919	6/30/2021
2021 Q1	5/6/2021	19,913	0.0%	216,355	3/31/2021
2020 Q4	2/10/2021	16,686	0.0%	228,101	12/31/2020
2020 Q3	11/12/2020	17,805	0.0%	229,211	9/30/2020
2020 Q2	8/13/2020	12,611	0.0%	226,892	6/30/2020
2020 Q1	5/6/2020	6,624	0.0%	223,625	3/31/2020
2019 Q4	2/5/2020	6,695	0.0%	184,955	12/31/2019